Esperion Therapeutics, Inc. · NASDAQ:ESPR
Wasatch Advisors LP's stake in Esperion Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 12, 2025
Wasatch Advisors LP's stake in Esperion Therapeutics, Inc. fell to 3.50%, 7,061,857 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G/A).
- Stake
- 3.50%
- Shares
- 7,061,857
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wasatch Advisors LP | 3.50% | 7,061,857 |
Source
Related
- Esperion Therapeutics, Inc.
- Wasatch Advisors LP
- Esperion Therapeutics, Inc. shareholders
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Schedule 13G · Wasatch Advisors LP · Apr 22, 2026
- Schedule 13G/A · Wasatch Advisors LP · Apr 7, 2025
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026
- Form 4 · Shepard Jay · Jul 13, 2026